Epidemiology

You have full text access to this OnlineOpen article

Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study†

  1. Jiyoung Ahn1,
  2. Roxana Moslehi1,
  3. Stephanie J. Weinstein1,
  4. Kirk Snyder2,
  5. Jarmo Virtamo3,
  6. Demetrius Albanes1,‡,*

Article first published online: 10 JUN 2008

DOI: 10.1002/ijc.23591

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 5, pages 1154–1159, 1 September 2008

Additional Information

How to Cite

Ahn, J., Moslehi, R., Weinstein, S. J., Snyder, K., Virtamo, J. and Albanes, D. (2008), Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Int. J. Cancer, 123: 1154–1159. doi: 10.1002/ijc.23591

Author Information

  1. 1

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD

  2. 2

    Information Management Services, Inc., Silver Spring, MD

  3. 3

    Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland

  1. ‡

    Fax: +301-496-6829.

*Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, EPS-3044, 6120 Executive Blvd, Bethesda, MD 20892, USA

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 17 JUN 2008
  2. Article first published online: 10 JUN 2008
  3. Manuscript Accepted: 5 MAR 2008
  4. Manuscript Received: 19 OCT 2007

Funded by

  • Department of Health and Human Services (Public Health Service). Grant Numbers: N01-CN-45165, N01-RC-45035, N01-RC-37004
  • Intramural Research Program of the National Institutes of Health
  • Division of Cancer Epidemiology and Genetics
  • National Cancer Institute

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (94K)

References

  • 1
    American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
  • 2
    Johns LE,Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003; 91: 789–94.
    Direct Link:
  • 3
    Staples MP,Giles GG,English DR,McCredie MR,Severi G,Cui JS,Hopper JL. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control 2003; 14: 161–6.
  • 4
    Cotter MP,Gern RW,Ho GY,Chang RY,Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 2002; 50: 216–21.
    Direct Link:
  • 5
    Bai Y,Gao YT,Deng J,Sesterhenn IA,Fraumeni JF,Hsing AW. Risk of prostate cancer and family history of cancer: a population-based study in China. Prostate Cancer Prostatic Dis 2005; 8: 60–5.
  • 6
    Negri E,Pelucchi C,Talamini R,Montella M,Gallus S,Bosetti C,Franceschi S,La Vecchia C. Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer 2005; 114: 648–52.
    Direct Link:
  • 7
    Hayes RB,Liff JM,Pottern LM,Greenberg RS,Schoenberg JB,Schwartz AG,Swanson GM,Silverman DT,Brown LM,Hoover RN. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361–4.
    Direct Link:
  • 8
    Bratt O,Kristoffersson U,Lundgren R,Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer 1997; 33: 2237–40.
  • 9
    Gronberg H,Wiklund F,Damber JE. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations. Cancer 1999; 86: 477–83.
  • 10
    Gronberg H,Damber L,Damber JE. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996; 77: 138–43.
    Direct Link:
  • 11
    Giovannucci E,Rimm EB,Liu Y,Leitzmann M,Wu K,Stampfer MJ,Willett WC. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 2003; 95: 1240–4.
  • 12
    Rohrmann S,Roberts WW,Walsh PC,Platz EA. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 2003; 55: 140–6.
    Direct Link:
  • 13
    Guttmacher AE,Collins FS,Carmona RH. The family history–more important than ever. N Engl J Med 2004; 351: 2333–6.
  • 14
    Yoon PW,Scheuner MT,Peterson-Oehlke KL,Gwinn M,Faucett A,Khoury MJ. Can family history be used as a tool for public health and preventive medicine? Genet Med 2002; 4: 304–10.
  • 15
    The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1–10.
  • 16
    Korhonen P,Malila N,Pukkala E,Teppo L,Albanes D,Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort–accuracy and delay. Acta Oncol 2002; 41: 381–8.
  • 17
    Virtamo J,Pietinen P,Huttunen JK,Korhonen P,Malila N,Virtanen MJ,Albanes D,Taylor PR,Albert P. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476–85.
  • 18
    AJCC. Cancer staging manual. Philadelphia: Lippincott-Raven, 1997.
  • 19
    Milne DB,Botnen J. Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986; 32: 874–6.
  • 20
    Damber L,Gronberg H,Damber JE. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden. Int J Cancer 1998; 78: 293–7.
    Direct Link:
  • 21
    Schuurman AG,Zeegers MP,Goldbohm RA,van den Brandt PA. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 1999; 10: 192–5.
  • 22
    Rodriguez C,Calle EE,Miracle-McMahill HL,Tatham LM,Wingo PA,Thun MJ,Heath CW,Jr. Family history and risk of fatal prostate cancer. Epidemiology 1997; 8: 653–7.
  • 23
    Spitz MR,Currier RD,Fueger JJ,Babaian RJ,Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 1305–7.
  • 24
    Hayes RB,Liff JM,Pottern LM,Greenberg RS,Schoenberg JB,Schwartz AG,Swanson GM,Silverman DT,Brown LM,Hoover RN. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361–4.
    Direct Link:
  • 25
    Ghadirian P,Howe GR,Hislop TG,Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 1997; 70: 679–81.
    Direct Link:
  • 26
    Bratt O,Kristoffersson U,Lundgren R,Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999; 35: 272–7.
  • 27
    Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13: 739–44.
    Direct Link:
  • 28
    Rodriguez C,McCullough ML,Mondul AM,Jacobs EJ,Chao A,Patel AV,Thun MJ,Calle EE. Meat consumption among Black and White men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2006; 15: 211–16.
  • 29
    Cross AJ,Peters U,Kirsh VA,Andriole GL,Reding D,Hayes RB,Sinha R. A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 2005; 65: 11779–84.
  • 30
    Cerhan JR,Parker AS,Putnam SD,Chiu BC,Lynch CF,Cohen MB,Torner JC,Cantor KP. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999; 8: 53–60.
  • 31
    Carter BS,Beaty TH,Steinberg GD,Childs B,Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 3367–71.
  • 32
    Lichtenstein P,Holm NV,Verkasalo PK,Iliadou A,Kaprio J,Koskenvuo M,Pukkala E,Skytthe A,Hemminki K. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78–85.
  • 33
    Xu J,Dimitrov L,Chang BL,Adams TS,Turner AR,Meyers DA,Eeles RA,Easton DF,Foulkes WD,Simard J,Giles GG,Hopper JL, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005; 77: 219–29.
  • 34
    Yeager M,Orr N,Hayes RB,Jacobs KB,Kraft P,Wacholder S,Minichiello MJ,Fearnhead P,Yu K,Chatterjee N,Wang Z,Welch R, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645–9.
  • 35
    Chang ET,Smedby KE,Hjalgrim H,Porwit-MacDonald A,Roos G,Glimelius B,Adami HO. Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 2005; 97: 1466–74.
  • 36
    Sellers TA,Kushi LH,Potter JD,Kaye SA,Nelson CL,McGovern PG,Folsom AR. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 1992; 326: 1323–9.
  • 37
    Murff HJ,Spigel DR,Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004; 292: 1480–9.
  • 38
    Kleinbaum DG,Kupper LL,Morgenstern H. Epidemiologic research. New York, NY: Van Nostrand Reinhold Company, 1982.
  • 39
    Madlensky L,Flatt SW,Bardwell WA,Rock CL,Pierce JP. Is family history related to preventive health behaviors and medical management in breast cancer patients? Breast Cancer Res Treat 2005; 90: 47–54.
View Full Article (HTML) Get PDF (94K)